The global protein a resin market was valued at USD 833 million in 2022 to USD 1,586 million by 2029, progressing at a CAGR of 9.6% from 2023 to 2029, according to the latest market study results.
This industry report offers market estimates of the global market, followed by a detailed analysis of the product, type, application, end user, and region. The global market data on protein a resin can be segmented by product: agarose-based protein A, glass and silica-based protein A, organic polymer-based protein A. According to the research, the agarose-based protein A segment had the largest share in the global protein a resin market. Protein a resin market is further segmented by type: natural protein A, recombinant protein A. In 2022, the natural protein A segment made up the largest share of revenue generated by the protein a resin market. Based on application, the protein a resin market is segmented into: antibody purification, immunoprecipitation. Among these, the antibody purification segment was accounted for the highest revenue generator in 2022. On the basis of end user, the protein a resin market also can be divided into: pharmaceutical and biopharmaceutical companies, research institutes, others. The pharmaceutical and biopharmaceutical companies segment captured the largest share of the market in 2022. Protein a resin market by region is categorized into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America.
The global protein a resin market is highly competitive. The report also includes the profiles of leading companies such as Agilent Technologies Inc., Avantor Inc., Bio-Rad Laboratories Inc., GE Healthcare, Genscript Biotech Corp., Kaneka Corporation, Merck & Co., Novasep Holding SAS, PerkinElmer Inc., Purolite Corporation, Repligen Corporation, Takara Bio Inc., Thermo Fisher Scientific Inc., Tosoh Corporation.
The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.
Why buy this report?
• Get a detailed picture of the Global Protein A Resin Market
• Identify segments/areas to invest in over the forecast period in the Global Protein A Resin Market
• Understand the competitive environment, the market's leading players
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.
Part 1. Summary
Part 2. Introduction
· Study period
· Geographical scope
· Market segmentation
Part 3. Protein a resin market overview
Part 4. Market breakdown by product
· Agarose-based protein A
· Glass and silica-based protein A
· Organic polymer-based protein A
Part 5. Market breakdown by type
· Natural protein A
· Recombinant protein A
Part 6. Market breakdown by application
· Antibody purification
· Immunoprecipitation
Part 7. Market breakdown by end user
· Pharmaceutical and biopharmaceutical companies
· Research institutes
· Others
Part 8. Market breakdown by region
· North America
· Europe
· Asia-Pacific
· MEA (Middle East and Africa)
· Latin America
Part 9. Key companies
· Agilent Technologies Inc.
· Avantor, Inc.
· Bio-Rad Laboratories Inc.
· GE Healthcare
· Genscript Biotech Corp.
· Kaneka Corporation
· Merck & Co.
· Novasep Holding SAS
· PerkinElmer Inc.
· Purolite Corporation
· Repligen Corporation
· Takara Bio Inc.
· Thermo Fisher Scientific Inc.
· Tosoh Corporation
Part 10. Methodology